SPONSOR
UNC Lineberger Comprehensive Cancer Center
Total Trials
14
Recruiting
14
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: SarcomaChronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsUnspecified Adult Solid Tumor, Protocol Specific
UNC Lineberger Comprehensive Cancer Center is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Sarcoma, Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia.
The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — UNC Lineberger Comprehensive Cancer Center
How many clinical trials has UNC Lineberger Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by UNC Lineberger Comprehensive Cancer Center, of which 14 are actively recruiting participants. These trials cover conditions including Sarcoma, Chronic Myeloproliferative Disorders, Cognitive/Functional Effects. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does UNC Lineberger Comprehensive Cancer Center research focus on?
UNC Lineberger Comprehensive Cancer Center clinical trials span Sarcoma, Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia, Lymphoma, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a UNC Lineberger Comprehensive Cancer Center clinical trial?
To participate in a UNC Lineberger Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all UNC Lineberger Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by UNC Lineberger Comprehensive Cancer Center
NCT06073067
Recruiting
GRID Therapy for Extremity Soft Tissue Sarcoma
Sarcoma
NCT01137825
Recruiting
Registry of Older Patients With Cancer
Chronic Myeloproliferative Disorders
NCT07084168
Recruiting
Multimedia Aid for Genetic Testing in Gynecologic Oncology
Ovary Cancer
NCT06902376 Phase 1
Recruiting
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Anaplastic Thyroid Cancer
NCT07685938 Phase 2
Recruiting
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Chest Wall Tumor
NCT04564989
Recruiting
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Oropharyngeal Squamous Cell Carcinoma
NCT05366179 Phase 1
Recruiting
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Glioblastoma Multiforme
NCT07340541 Phase 2
Recruiting
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Breast Cancer
NCT07867002 Phase 3
Recruiting
Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer
Endometrial Adenocarcinoma
NCT05440929
Recruiting
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Metastatic Breast Cancer
NCT07479199
Recruiting
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
Thoracic Neoplasms
NCT06855654
Recruiting
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Breast Cancer
NCT04083495 Phase 2
Recruiting
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Peripheral T Cell Lymphoma
NCT07788339
Recruiting
Keep Social Randomized Controlled Trial for Young Adults With Cancer
Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology